ReST THERAPEUTICS Revenue

Biotechnology Research • New Haven, Connecticut, United States • 1-10 Employees

ReST THERAPEUTICS revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contact at ReST THERAPEUTICS

Gilles Rubinstenn

Founder, Chairman Of The Board And Cio

Company overview

Headquarters	101 College St, New Haven, Connecticut 06510, US
Website	rest-therapeutics.com
Keywords	Neuropsychiatry, Ptsd, Neurodegeneration, Pharmaceutical Development, Neuroinflammation
Founded	2020
Employees	1-10
Socials

ReST THERAPEUTICS Email Formats

ReST THERAPEUTICS uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@rest-therapeutics.com), used 85.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@rest-therapeutics.com	85.7%
{first initial}.{last name}	j.doe@rest-therapeutics.com	14.3%

About ReST THERAPEUTICS

ReST Therapeutics is developing transformative therapies for patients with significant unmet needs in Psychiatry and Neurodegeneration. Our lead program, RST-01, will disrupt the existing PTSD treatment paradigm, focusing on early intervention in the aftermath of a traumatic event and a patient-centric clinical strategy. RST-01 targets specific NMDA receptors sub-types, critical to memory consolidation. Pre-clinical testing has shown drastic reductions in fear, anxiety and depression, as well as the restoration of cognitive function. Finally, reduced neuroinflammation in neurodegenerative models paves the way for an extended development portfolio focusing on restoring the quality of lives of those affected by these debilitating diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Manager

Entry

Employees by Department

ReST THERAPEUTICS has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore ReST THERAPEUTICS's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-06-17	9	N/A
2023-11-30	9	N/A

Funding Insights

Number of funding rounds

ReST THERAPEUTICS Tech Stack

Discover the technologies and tools that power ReST THERAPEUTICS's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Varnish

Caching

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Google Font API

Font scripts

jQuery Migrate

JavaScript libraries

Frequently asked questions

ReST THERAPEUTICS is located in New Haven, Connecticut, US.

ReST THERAPEUTICS generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

ReST THERAPEUTICS has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ReST THERAPEUTICS was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

ReST THERAPEUTICS has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ReST THERAPEUTICS

Gilles Rubinstenn

Founder, Chairman Of The Board And Cio

4.8

40,000 users